Australia, May 1 -- Vertex Pharmaceuticals Inc., owns the trademark (2500869) for 'ALYFTREK' and 'ARC THRU PATTERN OF DOTS' till Oct. 15, 2034.
Status: protected:
Registered/protected
Class: 5 [Pharmaceutical preparations for the treatment of cystic fibrosis.]
Type of Mark: Figurative
Date of Acceptance: Nov. 26, 2024
Registration Advertised: April 30
For further details contact Sarah Anne Keefe Womble Bond Dickinson (US) LLP .
The original document can be viewed at: https://search.ipaustralia.gov.au/trademarks/search/view/2500869.
Disclaimer: Curated by HT Syndication....